Breaking the glass ceiling of age in transplant in myeloma
ASH 2019, Orlando – Even though autologous hematopoietic cell transplantation (AHCT), a form of stem cell therapy, is an effective treatment for multiple myeloma, only four out of 10 patients receive this therapy. Myeloma occurs most often in people over 60 and the age is usually the main reason for avoiding this procedure.